NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Belinda Nicolau

CRC Tier 2 - Chronic oral disease (COD) aetiology

Nasopharynx Oesophagus

Pediatric oncology or childhood cancer

Victoria Harding

The role of miRNAs in regulation and signalling induced by a new oncogenic kinase, LMTK3

Breast

Ian M Thompson

San Antonio Center for Biomarkers of Risk For Prostate Cancer (SABOR)

Prostate

Pathology

Philip Lazarus

Role of Pharmacogenetics on Exemestane Metabolism and Toxicity

Breast

Investigator from King's College London

Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets

Breast

Simona Parrinello

Cell Interactions and Cancer

Brain, nervous system

Pathology

David Ross

Biochemical and Molecular Studies on NQO1. Design of Less Toxic Hsp90 Inhibitors

Pancreas Breast

Wan Lam

An integrative approach to understand lung cancer development in smokers and non-smokers

Trachea, bronchus and lung

Pathology

Richard Aplenc

Toxicity Monitoring on Phase III Trials with Administrative Data

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer